DIG
AEON icon

Dauntless Investment Group’s AEON Biopharma AEON Stock Holding History

Dauntless Investment Group’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.49M Buy
2,527,775
+395,923
+19% +$443K 1.65% 10
2025
Q4 		$1.32M Buy
2,131,852
+1,006,852
+89% +$941K 1.05% 14
2025
Q3 		$910K Hold
1,125,000
– – 0.57% 29
2025
Q2 		$475K Buy
1,125,000
+100,000
+10% +$57.4K 0.83% 23
2025
Q1 		$594K Buy
+1,025,000
New +$7.3M 0.7% 27

Other funds holding AEON

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dauntless Investment Group's AEON Position: Q1 2026 in Review

Dauntless Investment Group increased its AEON Biopharma (AEON) stake by 19% in Q1 2026, buying an estimated $443K and bringing the position to 2,527,775 shares worth $2.49M. The position accounts for 1.65% of the portfolio, ranked #10.

Dauntless Investment Group first reported a position in AEON in Q1 2025 and has held it in 5 quarters since. 24 funds tracked by Wall St. Rank hold AEON as of Q1 2026.

  • Dauntless Investment Group held 2,527,775 shares of AEON Biopharma worth $2.49M as of Q1 2026.
  • Dauntless Investment Group bought 395,923 AEON Biopharma shares in Q1 2026, an estimated $443K.
  • AEON Biopharma made up 1.65% of Dauntless Investment Group's portfolio in Q1 2026, its #10 holding.
  • Dauntless Investment Group first reported a position in AEON Biopharma in Q1 2025 and has held it in 5 quarters since.
  • 24 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2026.

Based on Dauntless Investment Group's 13F filing for Q1 2026, filed 14 May 2026.